Kristyn Masters
Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calcinosis | 15 | 2022 | 242 | 5.070 |
Why?
| Aortic Valve | 17 | 2022 | 397 | 4.590 |
Why?
| Extracellular Matrix | 20 | 2022 | 436 | 3.740 |
Why?
| Tissue Engineering | 13 | 2021 | 366 | 3.310 |
Why?
| Aortic Valve Stenosis | 7 | 2022 | 272 | 3.150 |
Why?
| Biocompatible Materials | 15 | 2018 | 369 | 2.420 |
Why?
| Heart Valve Diseases | 7 | 2017 | 159 | 1.950 |
Why?
| Hyaluronic Acid | 7 | 2013 | 189 | 1.910 |
Why?
| Polyurethanes | 5 | 2013 | 34 | 1.840 |
Why?
| Epidermal Growth Factor | 6 | 2016 | 162 | 1.780 |
Why?
| Nylons | 8 | 2014 | 18 | 1.770 |
Why?
| Keratinocytes | 6 | 2016 | 216 | 1.760 |
Why?
| Cell Culture Techniques | 8 | 2019 | 344 | 1.430 |
Why?
| Swine | 18 | 2017 | 705 | 1.360 |
Why?
| Immobilized Proteins | 3 | 2016 | 11 | 1.270 |
Why?
| Myofibroblasts | 3 | 2017 | 116 | 1.240 |
Why?
| Cell Movement | 11 | 2019 | 866 | 1.220 |
Why?
| Cell Adhesion | 14 | 2018 | 430 | 1.140 |
Why?
| Collagen | 7 | 2017 | 416 | 1.110 |
Why?
| Endothelial Cells | 5 | 2017 | 686 | 1.110 |
Why?
| Cell Proliferation | 15 | 2017 | 2192 | 1.060 |
Why?
| Heart Valves | 5 | 2010 | 41 | 1.040 |
Why?
| Cells, Cultured | 20 | 2022 | 3897 | 1.000 |
Why?
| Fibroblasts | 7 | 2013 | 839 | 0.870 |
Why?
| Fibronectins | 5 | 2021 | 108 | 0.790 |
Why?
| Wound Healing | 5 | 2016 | 259 | 0.780 |
Why?
| Osteoblasts | 2 | 2012 | 106 | 0.750 |
Why?
| Gelatin | 2 | 2017 | 36 | 0.720 |
Why?
| Simvastatin | 2 | 2012 | 59 | 0.720 |
Why?
| Animals | 35 | 2021 | 31884 | 0.700 |
Why?
| Surface Properties | 11 | 2013 | 387 | 0.670 |
Why?
| Laminin | 3 | 2015 | 69 | 0.640 |
Why?
| Gene Expression Regulation | 7 | 2017 | 2330 | 0.640 |
Why?
| Fibrosis | 2 | 2022 | 455 | 0.620 |
Why?
| Mentors | 2 | 2017 | 158 | 0.610 |
Why?
| Cell Communication | 4 | 2018 | 280 | 0.600 |
Why?
| Contracts | 1 | 2017 | 9 | 0.600 |
Why?
| NIH 3T3 Cells | 9 | 2014 | 137 | 0.580 |
Why?
| Phospholipase C gamma | 2 | 2019 | 26 | 0.580 |
Why?
| Science | 1 | 2017 | 49 | 0.560 |
Why?
| Signal Transduction | 5 | 2018 | 4527 | 0.550 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 372 | 0.550 |
Why?
| Methacrylates | 1 | 2017 | 106 | 0.550 |
Why?
| Actins | 4 | 2012 | 383 | 0.540 |
Why?
| Atherosclerosis | 1 | 2019 | 341 | 0.520 |
Why?
| Documentation | 1 | 2017 | 169 | 0.520 |
Why?
| Tissue Scaffolds | 4 | 2021 | 179 | 0.510 |
Why?
| Hyperlipoproteinemia Type II | 1 | 2015 | 26 | 0.510 |
Why?
| Muscle Proteins | 1 | 2017 | 210 | 0.500 |
Why?
| Interprofessional Relations | 1 | 2017 | 253 | 0.500 |
Why?
| Polymers | 6 | 2015 | 448 | 0.490 |
Why?
| Osteocalcin | 2 | 2012 | 34 | 0.490 |
Why?
| Pluripotent Stem Cells | 1 | 2015 | 63 | 0.480 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 349 | 0.460 |
Why?
| Intracranial Aneurysm | 1 | 2014 | 91 | 0.430 |
Why?
| Communication | 2 | 2023 | 744 | 0.430 |
Why?
| RNA | 2 | 2017 | 810 | 0.430 |
Why?
| Extracellular Matrix Proteins | 2 | 2014 | 126 | 0.420 |
Why?
| Cell Differentiation | 9 | 2018 | 1700 | 0.420 |
Why?
| Materials Testing | 6 | 2017 | 345 | 0.420 |
Why?
| Apoptosis | 8 | 2017 | 2368 | 0.420 |
Why?
| Molecular Structure | 8 | 2014 | 438 | 0.420 |
Why?
| Computer Simulation | 2 | 2018 | 879 | 0.410 |
Why?
| Embolization, Therapeutic | 1 | 2014 | 179 | 0.410 |
Why?
| Adsorption | 4 | 2013 | 119 | 0.400 |
Why?
| Macrophages | 3 | 2015 | 1267 | 0.400 |
Why?
| Fallopian Tubes | 2 | 2022 | 29 | 0.390 |
Why?
| Cystadenocarcinoma, Serous | 2 | 2022 | 43 | 0.380 |
Why?
| Peptides | 4 | 2014 | 849 | 0.380 |
Why?
| Dermatan Sulfate | 1 | 2010 | 3 | 0.370 |
Why?
| Biofouling | 1 | 2010 | 7 | 0.370 |
Why?
| Gene Regulatory Networks | 1 | 2012 | 229 | 0.360 |
Why?
| Phenotype | 7 | 2021 | 2814 | 0.360 |
Why?
| rho GTP-Binding Proteins | 1 | 2010 | 61 | 0.360 |
Why?
| Algorithms | 1 | 2017 | 1488 | 0.350 |
Why?
| Biomarkers | 7 | 2021 | 3422 | 0.350 |
Why?
| Hydrogels | 7 | 2019 | 575 | 0.350 |
Why?
| Tissue Culture Techniques | 3 | 2017 | 66 | 0.340 |
Why?
| Candida albicans | 3 | 2015 | 51 | 0.340 |
Why?
| Integrins | 1 | 2010 | 79 | 0.340 |
Why?
| Gene Expression | 2 | 2012 | 1424 | 0.340 |
Why?
| Regeneration | 1 | 2011 | 161 | 0.340 |
Why?
| Adipogenesis | 1 | 2009 | 42 | 0.330 |
Why?
| Research Personnel | 2 | 2021 | 151 | 0.330 |
Why?
| Biomimetic Materials | 1 | 2009 | 64 | 0.320 |
Why?
| Flow Cytometry | 3 | 2021 | 1084 | 0.320 |
Why?
| Stem Cells | 2 | 2011 | 547 | 0.320 |
Why?
| Cell Line | 5 | 2017 | 2645 | 0.310 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 146 | 0.310 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 164 | 0.310 |
Why?
| Adipocytes | 1 | 2009 | 189 | 0.300 |
Why?
| Humans | 31 | 2023 | 115222 | 0.300 |
Why?
| Transforming Growth Factor beta1 | 1 | 2008 | 154 | 0.300 |
Why?
| MAP Kinase Signaling System | 1 | 2009 | 276 | 0.290 |
Why?
| Ovarian Neoplasms | 2 | 2022 | 387 | 0.280 |
Why?
| Heart Valve Prosthesis | 2 | 2005 | 122 | 0.270 |
Why?
| Insulin-Like Growth Factor I | 1 | 2008 | 286 | 0.270 |
Why?
| Amino Acids | 1 | 2009 | 451 | 0.270 |
Why?
| Mice | 12 | 2020 | 14934 | 0.260 |
Why?
| Molecular Weight | 3 | 2013 | 331 | 0.250 |
Why?
| Cell Survival | 5 | 2017 | 1022 | 0.250 |
Why?
| S-Nitrosothiols | 1 | 2005 | 4 | 0.250 |
Why?
| Nitric Oxide Donors | 1 | 2005 | 15 | 0.250 |
Why?
| Bioprosthesis | 1 | 2005 | 37 | 0.240 |
Why?
| Tunica Intima | 1 | 2005 | 78 | 0.240 |
Why?
| Antifungal Agents | 3 | 2015 | 129 | 0.240 |
Why?
| Biomedical Engineering | 2 | 2018 | 23 | 0.230 |
Why?
| Cysteine | 1 | 2005 | 171 | 0.230 |
Why?
| Mass Behavior | 1 | 2023 | 3 | 0.220 |
Why?
| Time Factors | 5 | 2015 | 6157 | 0.210 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 796 | 0.210 |
Why?
| Gelatinases | 1 | 2022 | 6 | 0.210 |
Why?
| Ligands | 2 | 2018 | 565 | 0.210 |
Why?
| Fallopian Tube Neoplasms | 1 | 2022 | 13 | 0.200 |
Why?
| Culture Media, Serum-Free | 3 | 2012 | 42 | 0.200 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 928 | 0.200 |
Why?
| Bacterial Adhesion | 2 | 2013 | 78 | 0.200 |
Why?
| Cytokines | 3 | 2021 | 1843 | 0.200 |
Why?
| Carcinoma in Situ | 1 | 2022 | 43 | 0.200 |
Why?
| Matrix Metalloproteinases | 1 | 2022 | 89 | 0.200 |
Why?
| Staining and Labeling | 1 | 2022 | 135 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 6 | 2014 | 1860 | 0.190 |
Why?
| Monitoring, Immunologic | 1 | 2021 | 23 | 0.190 |
Why?
| Financial Management | 1 | 2021 | 15 | 0.190 |
Why?
| Cell Count | 2 | 2013 | 304 | 0.180 |
Why?
| Culture Media | 2 | 2017 | 155 | 0.180 |
Why?
| Women | 1 | 2020 | 51 | 0.180 |
Why?
| Immunophenotyping | 1 | 2021 | 276 | 0.180 |
Why?
| Oropharyngeal Neoplasms | 1 | 2020 | 39 | 0.170 |
Why?
| Immunohistochemistry | 2 | 2017 | 1635 | 0.170 |
Why?
| Cattle | 3 | 2013 | 925 | 0.170 |
Why?
| Azides | 2 | 2011 | 46 | 0.170 |
Why?
| Nitric Oxide | 1 | 2005 | 827 | 0.170 |
Why?
| Papillomaviridae | 1 | 2020 | 100 | 0.170 |
Why?
| Nasal Mucosa | 1 | 2020 | 94 | 0.170 |
Why?
| Workload | 1 | 2020 | 132 | 0.170 |
Why?
| rho-Associated Kinases | 2 | 2010 | 80 | 0.160 |
Why?
| Microfluidics | 2 | 2018 | 45 | 0.160 |
Why?
| Shock, Septic | 1 | 2021 | 186 | 0.160 |
Why?
| Disease Models, Animal | 3 | 2020 | 3547 | 0.160 |
Why?
| Solubility | 2 | 2010 | 224 | 0.160 |
Why?
| Antigens, CD | 1 | 2021 | 441 | 0.160 |
Why?
| Microfilament Proteins | 1 | 2019 | 126 | 0.160 |
Why?
| Platelet Adhesiveness | 2 | 2010 | 14 | 0.150 |
Why?
| Leukocytes, Mononuclear | 1 | 2021 | 496 | 0.150 |
Why?
| Biomedical Research | 2 | 2021 | 585 | 0.150 |
Why?
| Sex Characteristics | 1 | 2022 | 639 | 0.150 |
Why?
| Cations | 2 | 2014 | 79 | 0.150 |
Why?
| Lipopolysaccharides | 1 | 2021 | 818 | 0.150 |
Why?
| Interferon-gamma | 1 | 2021 | 724 | 0.150 |
Why?
| Glycosaminoglycans | 1 | 2017 | 79 | 0.150 |
Why?
| Proteins | 2 | 2013 | 915 | 0.140 |
Why?
| Lipoproteins, LDL | 1 | 2017 | 129 | 0.140 |
Why?
| Pressure | 1 | 2018 | 219 | 0.140 |
Why?
| Elastic Modulus | 1 | 2017 | 116 | 0.140 |
Why?
| Papillomavirus Infections | 1 | 2020 | 258 | 0.140 |
Why?
| Least-Squares Analysis | 2 | 2016 | 73 | 0.130 |
Why?
| DNA | 3 | 2013 | 1353 | 0.130 |
Why?
| Cross-Linking Reagents | 2 | 2008 | 181 | 0.130 |
Why?
| Cholesterol, LDL | 1 | 2017 | 308 | 0.130 |
Why?
| Molecular Probes | 1 | 2016 | 30 | 0.130 |
Why?
| Light | 3 | 2010 | 335 | 0.130 |
Why?
| Hydrogel, Polyethylene Glycol Dimethacrylate | 2 | 2009 | 74 | 0.130 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 114 | 0.130 |
Why?
| Recombinant Proteins | 2 | 2009 | 1237 | 0.130 |
Why?
| Cellular Microenvironment | 1 | 2016 | 78 | 0.130 |
Why?
| Female | 7 | 2022 | 59720 | 0.120 |
Why?
| Plaque, Atherosclerotic | 1 | 2015 | 44 | 0.120 |
Why?
| Embryoid Bodies | 1 | 2014 | 7 | 0.120 |
Why?
| Biomechanical Phenomena | 1 | 2017 | 676 | 0.120 |
Why?
| Tumor Microenvironment | 1 | 2017 | 431 | 0.120 |
Why?
| Bacillus cereus | 1 | 2014 | 5 | 0.120 |
Why?
| DNA Replication | 2 | 2014 | 202 | 0.120 |
Why?
| Erythrocytes | 2 | 2010 | 592 | 0.120 |
Why?
| Drug Resistance, Fungal | 1 | 2014 | 9 | 0.120 |
Why?
| Anti-Bacterial Agents | 2 | 2014 | 1481 | 0.120 |
Why?
| Antigens | 2 | 2006 | 318 | 0.120 |
Why?
| Cell Line, Tumor | 2 | 2019 | 2715 | 0.120 |
Why?
| Cerebral Angiography | 1 | 2014 | 111 | 0.110 |
Why?
| Embryonic Stem Cells | 1 | 2014 | 105 | 0.110 |
Why?
| Cholesterol | 1 | 2015 | 369 | 0.110 |
Why?
| Antibodies | 2 | 2006 | 372 | 0.110 |
Why?
| Gene Transfer Techniques | 1 | 2014 | 147 | 0.110 |
Why?
| Stress, Mechanical | 3 | 2010 | 449 | 0.110 |
Why?
| Salmonella enterica | 1 | 2014 | 49 | 0.110 |
Why?
| Acrylates | 2 | 2011 | 45 | 0.110 |
Why?
| U937 Cells | 1 | 2013 | 22 | 0.110 |
Why?
| Dogs | 1 | 2014 | 340 | 0.110 |
Why?
| Biofilms | 1 | 2015 | 223 | 0.110 |
Why?
| Vitronectin | 1 | 2012 | 4 | 0.100 |
Why?
| RNA, Small Interfering | 1 | 2014 | 541 | 0.100 |
Why?
| Transfection | 1 | 2014 | 872 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1323 | 0.100 |
Why?
| Oxidation-Reduction | 1 | 2015 | 926 | 0.100 |
Why?
| ErbB Receptors | 2 | 2019 | 555 | 0.100 |
Why?
| Mechanical Phenomena | 1 | 2013 | 80 | 0.100 |
Why?
| Hemodynamics | 1 | 2017 | 1024 | 0.100 |
Why?
| beta-Lactams | 1 | 2012 | 27 | 0.100 |
Why?
| Models, Biological | 2 | 2016 | 1638 | 0.100 |
Why?
| Alkaline Phosphatase | 1 | 2012 | 144 | 0.100 |
Why?
| Primary Cell Culture | 1 | 2012 | 149 | 0.100 |
Why?
| Pseudomonas aeruginosa | 1 | 2014 | 299 | 0.100 |
Why?
| Microscopy, Fluorescence | 2 | 2010 | 398 | 0.100 |
Why?
| Aging | 1 | 2021 | 1624 | 0.100 |
Why?
| Carbodiimides | 1 | 2011 | 4 | 0.100 |
Why?
| Genetic Markers | 1 | 2012 | 323 | 0.100 |
Why?
| Dermis | 1 | 2011 | 30 | 0.090 |
Why?
| Amines | 1 | 2011 | 36 | 0.090 |
Why?
| Stimulation, Chemical | 1 | 2010 | 57 | 0.090 |
Why?
| Chromatography, Gel | 1 | 2010 | 125 | 0.090 |
Why?
| Glycols | 1 | 2010 | 4 | 0.090 |
Why?
| Receptors, Laminin | 1 | 2010 | 2 | 0.090 |
Why?
| Integrin alpha5beta1 | 1 | 2010 | 9 | 0.090 |
Why?
| Osteogenesis | 1 | 2012 | 183 | 0.090 |
Why?
| Hyaluronan Receptors | 1 | 2010 | 91 | 0.090 |
Why?
| Blood Proteins | 1 | 2012 | 233 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 746 | 0.090 |
Why?
| Male | 4 | 2022 | 55814 | 0.090 |
Why?
| Adhesiveness | 1 | 2009 | 19 | 0.090 |
Why?
| Polyethylene Glycols | 3 | 2009 | 561 | 0.090 |
Why?
| Neovascularization, Physiologic | 1 | 2011 | 173 | 0.080 |
Why?
| Microfluidic Analytical Techniques | 1 | 2010 | 71 | 0.080 |
Why?
| Neoplasms | 1 | 2023 | 2106 | 0.080 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 157 | 0.080 |
Why?
| Oligosaccharides | 1 | 2009 | 46 | 0.080 |
Why?
| MAP Kinase Kinase 2 | 1 | 2009 | 27 | 0.080 |
Why?
| Butadienes | 1 | 2009 | 31 | 0.080 |
Why?
| Mechanotransduction, Cellular | 1 | 2010 | 97 | 0.080 |
Why?
| Cell Separation | 1 | 2010 | 291 | 0.080 |
Why?
| Mevalonic Acid | 1 | 2008 | 7 | 0.080 |
Why?
| Flavonoids | 1 | 2009 | 68 | 0.080 |
Why?
| MAP Kinase Kinase 1 | 1 | 2009 | 66 | 0.080 |
Why?
| Succinimides | 1 | 2008 | 15 | 0.080 |
Why?
| Rhodamines | 1 | 2008 | 17 | 0.080 |
Why?
| Polystyrenes | 1 | 2008 | 36 | 0.080 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 144 | 0.080 |
Why?
| Disease Progression | 1 | 2015 | 2390 | 0.080 |
Why?
| Age Factors | 1 | 2015 | 2900 | 0.080 |
Why?
| Gels | 1 | 2008 | 72 | 0.080 |
Why?
| Cell Line, Transformed | 1 | 2008 | 133 | 0.080 |
Why?
| Thermodynamics | 1 | 2010 | 383 | 0.080 |
Why?
| Nitriles | 1 | 2009 | 152 | 0.080 |
Why?
| Microbial Sensitivity Tests | 3 | 2014 | 300 | 0.080 |
Why?
| Structure-Activity Relationship | 3 | 2014 | 503 | 0.080 |
Why?
| Fibrin | 1 | 2008 | 65 | 0.080 |
Why?
| Bone and Bones | 1 | 2011 | 282 | 0.080 |
Why?
| Drug Synergism | 1 | 2008 | 317 | 0.080 |
Why?
| Breast Neoplasms | 1 | 2019 | 1865 | 0.080 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 401 | 0.070 |
Why?
| Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 76 | 0.070 |
Why?
| Sex Factors | 1 | 2012 | 1722 | 0.070 |
Why?
| Bacteria | 1 | 2013 | 728 | 0.070 |
Why?
| Fluorescent Dyes | 1 | 2008 | 300 | 0.070 |
Why?
| Curriculum | 1 | 2012 | 848 | 0.070 |
Why?
| Indoles | 1 | 2008 | 306 | 0.070 |
Why?
| Gene Expression Profiling | 1 | 2012 | 1524 | 0.060 |
Why?
| Phosphorylation | 1 | 2010 | 1574 | 0.060 |
Why?
| Enzyme Inhibitors | 1 | 2009 | 753 | 0.060 |
Why?
| Elastin | 1 | 2005 | 78 | 0.060 |
Why?
| Compressive Strength | 1 | 2005 | 70 | 0.060 |
Why?
| Protein Engineering | 1 | 2005 | 98 | 0.060 |
Why?
| Cyclic GMP | 1 | 2005 | 78 | 0.060 |
Why?
| Stress Fibers | 1 | 2004 | 16 | 0.060 |
Why?
| Blood Platelets | 1 | 2007 | 352 | 0.060 |
Why?
| Elasticity | 1 | 2005 | 190 | 0.060 |
Why?
| Calcium | 1 | 2010 | 1104 | 0.060 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2005 | 146 | 0.060 |
Why?
| Genetic Predisposition to Disease | 1 | 2012 | 2109 | 0.060 |
Why?
| Hydrophobic and Hydrophilic Interactions | 2 | 2014 | 176 | 0.060 |
Why?
| Carotid Arteries | 1 | 2005 | 183 | 0.050 |
Why?
| Polyvinyl Alcohol | 1 | 2002 | 13 | 0.050 |
Why?
| Myocytes, Smooth Muscle | 1 | 2005 | 236 | 0.050 |
Why?
| Versicans | 1 | 2021 | 5 | 0.050 |
Why?
| Reproducibility of Results | 1 | 2008 | 2806 | 0.050 |
Why?
| Meta-Analysis as Topic | 1 | 2021 | 161 | 0.050 |
Why?
| National Institutes of Health (U.S.) | 1 | 2021 | 106 | 0.050 |
Why?
| Oropharynx | 1 | 2020 | 36 | 0.040 |
Why?
| Workflow | 1 | 2021 | 136 | 0.040 |
Why?
| HLA-DR Antigens | 1 | 2021 | 221 | 0.040 |
Why?
| Rats | 2 | 2005 | 4980 | 0.040 |
Why?
| Rats, Sprague-Dawley | 1 | 2005 | 2216 | 0.040 |
Why?
| Peer Group | 1 | 2020 | 202 | 0.040 |
Why?
| Spheroids, Cellular | 1 | 2019 | 57 | 0.040 |
Why?
| Anesthesia | 1 | 2020 | 118 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2019 | 299 | 0.040 |
Why?
| Neoplasm Invasiveness | 1 | 2019 | 443 | 0.040 |
Why?
| Endoscopy | 1 | 2020 | 246 | 0.040 |
Why?
| Transcriptional Activation | 1 | 2019 | 337 | 0.040 |
Why?
| Social Support | 1 | 2020 | 528 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 1050 | 0.030 |
Why?
| Cell Aggregation | 1 | 2016 | 24 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2021 | 1816 | 0.030 |
Why?
| Proteomics | 1 | 2021 | 844 | 0.030 |
Why?
| Photochemistry | 2 | 2006 | 125 | 0.030 |
Why?
| Mothers | 1 | 2020 | 652 | 0.030 |
Why?
| Caregivers | 1 | 2020 | 716 | 0.030 |
Why?
| Case-Control Studies | 1 | 2021 | 3023 | 0.030 |
Why?
| Regression Analysis | 1 | 2016 | 949 | 0.030 |
Why?
| Models, Chemical | 2 | 2007 | 250 | 0.030 |
Why?
| 3T3 Cells | 1 | 2013 | 140 | 0.030 |
Why?
| Molecular Conformation | 1 | 2013 | 137 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 2013 | 165 | 0.030 |
Why?
| Behavior | 1 | 2012 | 91 | 0.030 |
Why?
| Hemolysis | 1 | 2013 | 146 | 0.030 |
Why?
| Awareness | 1 | 2012 | 92 | 0.020 |
Why?
| Rheumatic Heart Disease | 1 | 2011 | 5 | 0.020 |
Why?
| Cell Division | 2 | 2004 | 759 | 0.020 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 94 | 0.020 |
Why?
| Personal Satisfaction | 1 | 2012 | 182 | 0.020 |
Why?
| United States | 2 | 2021 | 12256 | 0.020 |
Why?
| Cell Size | 1 | 2010 | 81 | 0.020 |
Why?
| Shear Strength | 1 | 2010 | 65 | 0.020 |
Why?
| Tensile Strength | 1 | 2010 | 97 | 0.020 |
Why?
| Equipment Failure Analysis | 1 | 2010 | 135 | 0.020 |
Why?
| Learning | 1 | 2012 | 354 | 0.020 |
Why?
| Equipment Design | 1 | 2010 | 513 | 0.020 |
Why?
| Fluoresceins | 1 | 2007 | 46 | 0.020 |
Why?
| Antigen-Antibody Reactions | 1 | 2006 | 50 | 0.020 |
Why?
| Tetrazolium Salts | 1 | 2005 | 18 | 0.020 |
Why?
| Glucagon | 1 | 2005 | 93 | 0.020 |
Why?
| Thiazoles | 1 | 2005 | 110 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2005 | 305 | 0.010 |
Why?
| Microscopy, Phase-Contrast | 1 | 2002 | 18 | 0.010 |
Why?
| Hydroxyproline | 1 | 2002 | 22 | 0.010 |
Why?
| Kinetics | 1 | 2005 | 1558 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 1717 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2004 | 1133 | 0.010 |
Why?
|
|
Masters's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|